The development and validation of a staging system for non-metastatic prostate cancer could help doctors and patients assess treatment options, as well as improve clinical trials. Doctors and ...

Healthcare integration was associated with small declines in treatment, but no change in overtreatment of prostate cancer. Integrated care delivery alone may be insufficient to curtail overtreatment.

A research team from Harbin Institute of Technology has proposed a novel and effective robot system for ultrasound-guided prostate percutaneous intervention. The 8-joint robot system can realize a ...

Cornell silica nanoparticles eliminated prostate tumors in mice by triggering ferroptosis and activating immune response, ...

Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing PROSPeCT was designed and implemented to make it easy for ...

One of the most common concerns about treating prostate cancer is preserving sexual function and urinary control. For some prostate cancers, newer treatments offering an alternative to radiation and ...

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

DELRAY BEACH, Fla., May 2, 2017 /PRNewswire-USNewswire/ -- The Sperling Prostate Center is pleased to announce its participation as a new study site for a clinical study of MR-guided focused ...

Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes and inform treatment decisions for ...